Multivalent cytomegalovirus glycoprotein B nucleoside modified mRNA vaccines did not demonstrate a greater antibody breadth.

Saved in:
Bibliographic Details
Title: Multivalent cytomegalovirus glycoprotein B nucleoside modified mRNA vaccines did not demonstrate a greater antibody breadth.
Authors: Wang HY; Department of Pediatrics, Weill Cornell Medicine, New York, NY, 10065, USA.; Duke University Medical Center, Duke Human Vaccine Institute, Durham, NC, 27710, USA., Li L; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.; Takeda Pharmaceutical, San Diego, CA, 92121, USA., Nelson CS; Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA., Barfield R; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, 27710, USA.; Center for Human Systems Immunology, Duke University Medical Center, Durham, NC, 27710, USA., Valencia S; Duke University Medical Center, Duke Human Vaccine Institute, Durham, NC, 27710, USA., Chan C; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, 27710, USA.; Center for Human Systems Immunology, Duke University Medical Center, Durham, NC, 27710, USA., Muramatsu H; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA., Lin PJC; Acuitas Therapeutics, Vancouver, BC, V6T 1Z3, Canada., Pardi N; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA., An Z; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA., Weissman D; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA., Permar SR; Department of Pediatrics, Weill Cornell Medicine, New York, NY, 10065, USA. sallie.permar@med.cornell.edu.
Source: NPJ vaccines [NPJ Vaccines] 2024 Feb 20; Vol. 9 (1), pp. 38. Date of Electronic Publication: 2024 Feb 20.
Publication Type: Journal Article
Journal Info: Publisher: Springer Nature in partnership with the Sealy Center for Vaccine Development Country of Publication: England NLM ID: 101699863 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-0105 (Electronic) Linking ISSN: 20590105 NLM ISO Abbreviation: NPJ Vaccines Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38378950
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Multivalent cytomegalovirus glycoprotein B nucleoside modified mRNA vaccines did not demonstrate a greater antibody breadth.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wang+HY%22">Wang HY</searchLink>; Department of Pediatrics, Weill Cornell Medicine, New York, NY, 10065, USA.; Duke University Medical Center, Duke Human Vaccine Institute, Durham, NC, 27710, USA.<br /><searchLink fieldCode="AU" term="%22Li+L%22">Li L</searchLink>; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.; Takeda Pharmaceutical, San Diego, CA, 92121, USA.<br /><searchLink fieldCode="AU" term="%22Nelson+CS%22">Nelson CS</searchLink>; Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.<br /><searchLink fieldCode="AU" term="%22Barfield+R%22">Barfield R</searchLink>; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, 27710, USA.; Center for Human Systems Immunology, Duke University Medical Center, Durham, NC, 27710, USA.<br /><searchLink fieldCode="AU" term="%22Valencia+S%22">Valencia S</searchLink>; Duke University Medical Center, Duke Human Vaccine Institute, Durham, NC, 27710, USA.<br /><searchLink fieldCode="AU" term="%22Chan+C%22">Chan C</searchLink>; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, 27710, USA.; Center for Human Systems Immunology, Duke University Medical Center, Durham, NC, 27710, USA.<br /><searchLink fieldCode="AU" term="%22Muramatsu+H%22">Muramatsu H</searchLink>; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.<br /><searchLink fieldCode="AU" term="%22Lin+PJC%22">Lin PJC</searchLink>; Acuitas Therapeutics, Vancouver, BC, V6T 1Z3, Canada.<br /><searchLink fieldCode="AU" term="%22Pardi+N%22">Pardi N</searchLink>; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.<br /><searchLink fieldCode="AU" term="%22An+Z%22">An Z</searchLink>; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.<br /><searchLink fieldCode="AU" term="%22Weissman+D%22">Weissman D</searchLink>; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.<br /><searchLink fieldCode="AU" term="%22Permar+SR%22">Permar SR</searchLink>; Department of Pediatrics, Weill Cornell Medicine, New York, NY, 10065, USA. sallie.permar@med.cornell.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101699863%22">NPJ vaccines</searchLink> [NPJ Vaccines] 2024 Feb 20; Vol. 9 (1), pp. 38. <i>Date of Electronic Publication: </i>2024 Feb 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature+in+partnership+with+the+Sealy+Center+for+Vaccine+Development%22">Springer Nature in partnership with the Sealy Center for Vaccine Development </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101699863 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-0105 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220590105%22">20590105 </searchLink><i>NLM ISO Abbreviation: </i>NPJ Vaccines <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38378950
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41541-024-00821-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 38
    Titles:
      – TitleFull: Multivalent cytomegalovirus glycoprotein B nucleoside modified mRNA vaccines did not demonstrate a greater antibody breadth.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wang HY
      – PersonEntity:
          Name:
            NameFull: Li L
      – PersonEntity:
          Name:
            NameFull: Nelson CS
      – PersonEntity:
          Name:
            NameFull: Barfield R
      – PersonEntity:
          Name:
            NameFull: Valencia S
      – PersonEntity:
          Name:
            NameFull: Chan C
      – PersonEntity:
          Name:
            NameFull: Muramatsu H
      – PersonEntity:
          Name:
            NameFull: Lin PJC
      – PersonEntity:
          Name:
            NameFull: Pardi N
      – PersonEntity:
          Name:
            NameFull: An Z
      – PersonEntity:
          Name:
            NameFull: Weissman D
      – PersonEntity:
          Name:
            NameFull: Permar SR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 02
              Text: 2024 Feb 20
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2059-0105
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: NPJ vaccines
              Type: main
ResultId 1